Both in Pharmaceuticals
Assembly Biosciences vs Avalo Therapeutics
Over the past year ASMB returned −35.2% and AVTX returned −60.2%; their daily moves had a correlation of 0.32.
ASMB −35.2% AVTX −60.2%Growth of $1, one year, split-adjusted
| Metric | ASMB | AVTX |
|---|---|---|
| Price | $20.13 | $7.17 |
| Market cap | $409.9M | $384.5M |
| Today | −3.50% | −3.63% |
| 1 month | −12.4% | −52.0% |
| 6 months | −26.5% | −47.7% |
| Year to date | −40.8% | −60.5% |
| 1 year | −35.0% | −60.3% |
| Revenue growth (YoY) | +38.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −28.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.5× | 6,517.4× |
| Net cash | $320.4M | $400.3M |
| Dividend yield | — | — |
| Volatility (60d) | 63.4% | 114.9% |
| Short % of float | 28.0% | 24.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).